Healthcare
Biogen Inc.
BIIB$212.50-3.77%
Price is delayed.
Add to watchlist
About Biogen Inc.
Biogen is a biotechnology company focused on neurological diseases. They make drugs for multiple sclerosis and developed a controversial Alzheimer's drug. The company's future depends on whether their neuroscience pipeline can produce new successful treatments.
Loading chart...
Members only
Full research is for ConvictionStocks members
Members read the rest of this page. Where we have it for this company, that is:
- What each number means, in plain English, with the Wall Street name where the two differ.
- A plain-English summary of the company.
- How many analysts cover it, and the count behind each rating.
- Recent news, dated.
Get the free weekly market digest
The week's biggest movers, every Sunday. No spam.
Look up another company
Related Research
More Healthcare stocks to explore